Macrophage Activation Syndrome (MAS): A Case Report and Narrative Review

Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening syndrome of excessive inflammation and tissue destruction secondary to abnormal immune activation. The term macrophage activation syndrome (MAS) is used when HLH develops in the setting of systemic juvenile idiopathic arthritis...

Full description

Saved in:
Bibliographic Details
Published inCurēus (Palo Alto, CA) Vol. 15; no. 3; p. e35670
Main Authors Dilibe, Arthur, Ugoala, Onyinye S, Evbayekha, Endurance O, Khalilullah, Mohammad Z, Adabale, Olanrewaju K, Poyser, Tracy-Ann, Oriaifo, Osejie F, Olori, Ufuoma I, Aiwuyo, Henry O
Format Journal Article
LanguageEnglish
Published United States Cureus Inc 01.03.2023
Cureus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening syndrome of excessive inflammation and tissue destruction secondary to abnormal immune activation. The term macrophage activation syndrome (MAS) is used when HLH develops in the setting of systemic juvenile idiopathic arthritis (SJIA; formerly known as Still's disease), adult-onset Still's disease, or any other rheumatologic disorder. We present a case of a 21-year-old female with a known history of SJIA who presented to the hospital with fever, chills, myalgia, nausea, vomiting, and hypotension. Initial evaluation at the time of presentation suggested sepsis likely due to acute pyelonephritis, and the patient was started on antibiotics and intravenous fluid hydration. However, further workup suggested that her symptoms were non-infectious and were likely due to MAS, a rare complication of SJIA. We promptly diagnosed her, and she received a course of steroids and made an uneventful recovery.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.35670